A call for an industry-led initiative to critically assess machine learning for real-world drug discovery
Övrig text i vetenskaplig tidskrift, 2024

No abstract available

Författare

Cas Wognum

Recursion Pharmaceuticals

Valence Labs

Jeremy R. Ash

Johnson & Johnson Innovative Medicine

Matteo Aldeghi

Bayer Research and Innovation Center

Raquel Rodríguez-Pérez

Novartis International AG

Cheng Fang

Blueprint Medicines Corporation

Alan C. Cheng

Merck & Co., Inc.

Daniel J. Price

Nimbus Therapeutics

Djork Arné Clevert

Pfizer

Ola Engkvist

Chalmers, Data- och informationsteknik

AstraZeneca AB

W. Patrick Walters

Relay Therapeutics

Nature Machine Intelligence

25225839 (eISSN)

Vol. 6 10 1120-1121

Ämneskategorier

Datavetenskap (datalogi)

DOI

10.1038/s42256-024-00911-w

Mer information

Senast uppdaterat

2024-11-02